key: cord-0280961-w6vte3ob
authors: Srivastava, Saurabh; Verhagen, Andrea; Sasmal, Aniruddha; Wasik, Brian R.; Diaz, Sandra; Yu, Hai; Bensing, Barbara A.; Khan, Naazneen; Khedri, Zahra; Secrest, Patrick; Sullam, Paul; Varki, Nissi; Chen, Xi; Parrish, Colin R.; Varki, Ajit
title: Development and applications of sialoglycan-recognizing probes (SGRPs) with defined specificities: exploring the dynamic mammalian sialoglycome
date: 2021-05-28
journal: bioRxiv
DOI: 10.1101/2021.05.28.446202
sha: ebc2ece414cd4a5a5bb8a0acc84e949f57d1ce56
doc_id: 280961
cord_uid: w6vte3ob

Glycans that are abundantly displayed on vertebrate cell surface and secreted molecules are often capped with terminal sialic acids (Sias). These diverse 9-carbon-backbone monosaccharides are involved in numerous intrinsic biological processes. They also interact with commensals and pathogens, while undergoing dynamic changes in time and space, often influenced by environmental conditions. However, most of this sialoglycan complexity and variation remains poorly characterized by conventional techniques, which often tend to destroy or overlook crucial aspects of Sia diversity and/or fail to elucidate native structures in biological systems i.e., in the intact sialome. To date, in situ detection and analysis of sialoglycans has largely relied on the use of plant lectins, sialidases or antibodies, whose preferences (with certain exceptions) are limited and/or uncertain. We took advantage of naturally-evolved microbial molecules (bacterial adhesins, toxin subunits and viral hemagglutinin-esterases) that recognize sialoglycans with defined specificity to delineate 9 classes of Sialoglycan Recognizing Probes (SGRPs: SGRP1–SGRP9) that can be used to explore mammalian sialome changes in a simple and systematic manner, using techniques common in most laboratories. SGRP candidates with specificity defined by sialoglycan microarray studies were engineered as tagged probes, each with a corresponding non-binding mutant probe as a simple and reliable negative control. The optimized panel of SGRPs can be used in methods commonly available in most bioscience labs, such as ELISA, Western Blot, flow cytometry and histochemistry. To demonstrate the utility of this approach, we provide examples of sialoglycome differences in tissues from C57BL/6 wild type mice and human-like Cmah−/− mice.

All cells in nature are covered with a dense and complex array of sugar chains (1) , and in vertebrates the outermost ends of the branches on this glycan forest are often capped with monosaccharides called sialic acids (Sias), which have enormous intrinsic complexity (2, 3) . Most current methods to study this important and dynamic aspect of the glycome are too specialized for an average scientist to employ, and many aspects of this class of important molecules are thus poorly studied, even by experts. Given their ubiquitous presence and terminal position, Sias have been exploited as primary, transient or co-receptors by a diverse range of commensal or pathogenic microorganisms (4, 5) . These interactions are typically mediated by microbial proteins that have evolved with high binding specificity towards sialoglycans and can differentiate their target Sias by types, modifications, substitutions and/or linkage to underlying glycans.

In this report, we undertake a strategy to develop Sia-specific probes from such microbial proteins that have naturally evolved to recognize Sia complexity with great specificity, likely because of the ongoing evolutionary arms race between microbes and hosts. We have harnessed the Sia specificity of microbial proteins, and if found insufficient assessed other available probes to generate a simple and reliable toolkit that can be used to easily monitor dynamic changes of the sialic acids in normal and abnormal states. Specifically, this study advances a set of comprehensive sialoglycan-recognizing probes (SGRPs) that can confirm whether a biological sample has any sialic acids or not; if so, the type of common Sia variations (particularly O-acetylation), the linkage to underlying glycans, and the presence of N-acetyl or N-glycolyl groups. To identify candidates for such an updated set of probes for mammalian Sias, we assessed a number of Sia-specific binding proteins, novel or reported in accompanying or previous articles for their specificities towards different classes of mammalian Sia types and/or linkage to the underlying glycans.

Specifically, 9 types of SGRPs were defined from a subset of proteins including bacterial serinerich repeat (SRR) adhesins, bacterial B5 toxins, viral hemagglutinins (HAs) and hemagglutininesterases (HEs) and compared them to previously known invertebrate and plant lectins, selected Siglecs, and polyclonal and monoclonal antibodies (MAbs). Upon identification of the best SGRP for each class of sialoglycans, a mutant inactive probe was also developed as an internal control of each probe's specificity. To ensure minimal loss of sensitive Sia modifications/substitutions, experimental conditions were optimized, and the specificity of each probe was tested with positive and negative controls, such as pretreatment with specific sialidases or esterases, or mild periodate oxidation of the Sia side chain. The binding specificities of SGRPs were confirmed by testing on a sialoglycan microarray, constituting a diverse array of more than 100 

Defining distinct classes of Sialoglycan Recognizing Probes (SGRPs). We sought to define a set of SGRPs for detection of the most common types of mammalian sialoglycan variants, along with non-binding mutants as controls. This approach simplifies in-situ detection for all major types of Sias (SGRP1), typical N-acyl modifications at C-5 of Sias (SGRP2, SGRP5), linkages to underlying glycans (SGRP3, SGRP6, SGRP8) and occurrence of O-acetyl groups (SGRP4, SGRP7, SGRP9). We also suggested a SGRP numbering system (see Table 1 ) for these probes that make them easier to remember. To define a given probe, we used a superscript, and added NB for the non-binding control. Thus, for example, the Y. enterocolitica toxin B subunit (YenB) that recognizes all Neu5Ac and Neu5Gc forms and linkages is designated SGRP1 YenB and the nonbinding variant as SGRP1 YenB NB. The current set of SGRPs does not include probes specific for 2-keto-3-deoxy-D-glycero-D-galacto-nononic acid (Kdn), which, although naturally found in mammals, occurs in limited amounts and primarily in the free form (6) .

Search for naturally evolved microbial molecules with defined specificity towards specific aspects of sialoglycans. The SGRP candidates were defined by sialoglycan microarray studies, with each probe accompanied by a corresponding non-binding mutant as a negative control. The essential criterion for a protein to qualify as an SGRP was that it must show specificity towards the preferred Sia modification/linkages. The detailed analyses of most updated contemporary set of probes (SGRPs) and specificities and their practicability towards probing mammalian sialoglycans is discussed in subsequent sections. As mentioned in Table 1 , we could not identify any microbial candidate having a better or broader specificity for SGRP5 (N-glycolyl-Sias) than our previously described affinity--purified Neu5Gc chicken polyclonal IgY, or SGRP6 Sambucus nigra agglutinin (SNA), the conventionally used lectin probe for a2-6-linked Sias. SGRP1 YenB is a probe to detect all mammalian sialic acids. While a2-3Sia-binding MAL and a2-6Sia-binding SNA together recognize the majority of Sia linkages, their preferences cannot be generalized for all types of Sias. Previously, WGA and LFA have been reported as having broadspectrum Sia specificity, but their preferences towards Neu5Ac bring into question their utility as practicable probes to detect all types of Sias (7) (8) (9) . For an SGRP that binds all types of Sia, we first considered YpeB (Yersinia pestis Toxin B subunit that recognizes both Neu5Ac-and Neu5Gc-terminated glycans--detailed sialoglycan preferences are reported in the companion paper 1 (Khan et al., see also Figure S1 ). However, despite its ability to recognize most major classes of mammalian sialoglycans in glycan array and serum ELISAs, YpeB did not bind 4-OAc-Sias (Suppl. Fig S1) . Relying on the promising lead from YpeB, we investigated additional B subunits of AB5 bacterial toxins and selected YenB (Y. enterocolitica toxin B subunit) based on homology with YpeB and S. typhimurium ArtB, and broad host specificity (see companion paper, Sasmal et.al.). Using His6-tagged YenB (see Sasmal et al. accompanying paper) we confirmed the protein's recognition for both Neu5Ac and Neu5Gc including 9-O-and 4-O-acetylated Sias, a clear advantage over WGA, LFA and our initial candidate YpeB (Suppl. Figure S2) . Notably, YenB did not show any binding to non-sialylated glycans in the same assay, further confirming its extensive but Sia-selective binding to glycans. In order to biotinylate YenB without affecting its Sia-binding domain, we attempted to clone YenB with additional tags for biotinylation (SNAP, ACP and Avi) but the modifications resulted in poor protein quality and yield, leading to reduced binding of Sia in glycan arrays. A direct N-hydroxysuccinimide (NHS-)-biotin conjugation of YenB was therefore optimized to obtain the final biotinylated probe (SGRP1 YenB ) that showed no loss of binding preferences in comparison to non-biotinylated YenB. It was previously established that a serine residue contributes critically to Neu5Ac binding, while a tyrosine residue interacts with the extra OH group at the C5-acyl chain of Neu5Gc and is thus critical for its binding (10) . As described in a companion paper (Sasmal et.al.) , we aligned the YenB sequence with those of E.

coli SubB and S. typhimurium ArtB and predicted the conserved serine (S31) and tyrosine (Y100) in YenB. Mutating these critical sites for Sia recognition (YenB, S31A;Y100F) produced SGRP1 YenB NB as an internal control for Sia-binding SGRP1 YenB (Suppl. Fig. S3A &B) . The final binding and nonbinding specificities for SGRP1 YenB were tested on a sialoglycan microarray with nearly 130 mammalian sialoglycan types, suggesting all-inclusive Sia specificity in SGRP1, and a complete lack of Sia-binding by SGRP1 YenB NB (Suppl. Fig S4) . Since there were no other molecules known to possess YenB-like Sia specificities, the pair of SGRP1 YenB and SGRP1 YenB NB are currently the most appropriate probes to detect all mammalian Sia types. The utility of SGRP1 YenB as a useful tool of in situ Sia detection through ELISAs, Western Blotting, IHC and flow cytometry is described and discussed below.

SGRP2 PltB recognizes all Neu5Ac-terminated glycans. Neu5Ac is the most abundant Sia type and occurs in all Sia-expressing organisms. Mammals (including humans) that lack a functional CMAH enzyme have lost the ability to convert cytidine 5'-monophosphate N-acetylneuraminic acid (CMP-Neu5Ac) into CMP-Neu5Gc, and express excess Neu5Ac as their primary Sia type.

Despite such wide distribution and roles in human physiology/immunity, there has so far been no direct probe to selectively detect all forms and linkages of Neu5Ac in situ. Among commonly known probes for sialoglycans, WGA shows relative specificity towards Neu5Ac-glycans but neither recognizes all sialoglycans terminating with Neu5Ac, nor is it exclusive to Neu5Ac, showing a dual preference for Neu5Ac and GlcNAc (8) (Suppl Fig. S2A ). Previously, we identified Neu5Ac-specific binding in PltB, the B subunit of Typhoid toxin which preferred to bind human erythrocytes and tissues rich in Neu5Ac over the corresponding Neu5Gc-rich samples from Chimpanzees (11) . Similar Neu5Ac-specific patterns of PltB binding were further studied recently by others who also reported its binding O-acetylated Neu5Ac in both a2-3 and a2-6-linked sialoglycans (12) . In the accompanying paper (Sasmal et al.), we report on the binding of PltB to a range of naturally occurring Neu5Ac but not Neu5Gc-glycans, underlining PltB's appropriateness as a Neu5Ac-recognizing probe. We cloned the His6-tagged Neu5Ac-binding domain of PltB with an additional ACP tag (NEB) for biotinylation, but we then had to abandon this approach due to poor expression and purification quality of the resulting protein. The final probe version of PltB (SGRP2 PltB ) was derived by direct biotinylation of PltB with NHS-biotin. This biotinylated-PltB shows comparable specificity and avidity towards Neu5Ac glycans as the unmodified protein (Fig 1) . The Neu5Ac-binding domain of PltB was characterized previously and a serine residue was reported to be critical for Neu5Ac-binding by PltB (11) . Thus PltB S35A NB, an internal nonbinding mutant control of SGRP2 was also produced, biotinylated and included in all studies (Suppl. Fig S3 C & D) .

The sialoglycan microarray with mammalian sialoglycan types showed the Neu5Acspecific binding pattern of SGRP2 PltB while SGRP2 PltB NB completely lacks binding (Suppl. Fig   S4) . In agreement with previous data SGRP PltB (11) , high binding preferences towards Neu5Ac were seen regardless of substitutions, modifications, or linkages to underlying glycans. As shown in the array, SGRP2 PltB demonstrates comparable binding for a2-3, a2-6 and a2-8 linked Neu5Ac and clearly distinguishes them from a2-3, a2-6 or a2-8 linked Neu5Gc (Fig 1) . Notably, SGRP2 PltB also exhibited recognition for Neu4,5Ac2 and Neu5,9Ac2. Taken together, SGRP2 PltB showed definite superiority over WGA as Neu5Ac binding probe (Suppl Fig S2A) . We therefore prepared SGRP2 PltB and a SGRP2 PltB NB control as Neu5Ac-binding and non-binding probes for use in general methods such as ELISAs, Western blotting, flow cytometry and IHC.

SGRP3 Hsa selectively recognizes a2-3-linked Sias. Lectins from Maackia amurensis seeds, first reported by Kawaguchi et al (13) have been the gold standard for detection for Sias a2-3-linked to penultimate Gal. These lectins initially designated as 'strongly mitogenic M. amurensis leukoagglutinin (MAL) and 'strongly hemagglutinating M. amurensis hemagglutinin' (MAH) are commonly known as MAL-I and MAL-II, respectively. While both lectins require at least a Siaa2-3Gal disaccharide structure to bind, they differ in their requirement for specific structures. MAL-I shows stronger binding to Siaa2-3Galb1-4GlcNAc/Glc (a trisaccharide common in N-glycans) and MAH (MAL-II) is selective towards Siaa2-3Galb1-3GalNAc, typically found in O-linked glycans. Among Siaa2-3-linked structures tested, MAH prefers 9-O-acetyl Sias with Neu5Ac over Neu5Gc and Ser/Thr-linked O-glycan structures (14) (15) (16) . However, MAL-I can also recognize 3-O-sulfated Gal terminated oligosaccharides i.e., it does not show exclusivity towards sialylated sequences (17) . Instead, MAL-I displays widespread affinity towards a2-3-linked Neu5Ac and Neu5Gc, but with selective inclination towards Asn-linked over Ser/Thr-linked glycans. Attempts had been made to improve Maackia lectins (18) but this did not yield a general-purpose Siaa2-3recognizing probe.

We looked into the Sia-binding properties of previously reported Siglec-like-domaincontaining ligand-binding regions (BRs) of Streptococcus gordonii SRR adhesins (19) (20) (21) . In particular, we selected GspB-BR of S. gordonii strain M99, Hsa-BR of S. gordonii Stain DL1 (Challis), and UB10712-BR of S. gordonii strain UB10712, and investigated their suitability for a comprehensive Siaa2-3-linkage identifying probe. All 3 BRs were expressed as SNAPf-His6 fusions in the pGEX-3X vector in a bacterial expression system along with their non-binding variants HsaBR (R340E), GspBBR (R484E) and UB10712BR (R338E) (Suppl Fig S3) .

The pairs of HsaBR/HsaBRNB, GspBBR/GspBBRNB and UB10712BR/ UB10712BRNB were biotinylated using SNAP-benzyl guanine chemistry and tested for their sialoglycan binding on our microarray. Despite their structural similarities, the 3 biotinylated BRs displayed uniquely different ligand binding profiles, including differential recognition of sialyl Lewis antigens and sulfated glycans. While GspBBR selectively binds sialyl-T antigen (Neu5Aca2-3Galb1-3GalNAc) and related structures, HsaBR displays broader specificity covering NeuAca2-3Galb1-4GlcNAc and sialyl-T antigen (Fig 1 & Suppl Fig S5A) (20) (21) (22) . In comparison to HsaBR, GspBBR imparts lesser specificity towards a2-3 than a2-6 Sia linkages, (20) and falls short of the binding range of HsaBR, which not only includes trisaccharide and oligosaccharide but also disaccharide Sias. 9-O-Acetylation on Sia did not block GspBBR or HsaBR binding, but sulfation appeared to enhance HsaBR binding (21) . Sia binding preferences of UB10712BR remained comparable to a2-3 linked Sia specificities of HsaBR and GspBBR. UB10712BR bound to range of a2-3 Sia linkages including sialyl Lewis X, 3'-sialyllactosamine and their sulfated forms but preferred Neu5Ac over Neu5Gc sequences generally (Suppl Fig S5A) (19) ). Confirming the Sia-specificity of these BRs, the NB variants did not show any binding of Sia linkages/modifications on the array (Suppl Fig S4, S5) .

The data obtained with biotinylated BRs also agrees with previously published reports on GSTfusion BRs (19) (20) (21) (22) , and the comparable binding abilities of these biotinylated probes with the original BRs confirmed that biotinylation did not affect the Sia specificity of these proteins.

Considering the results with biotinylated-HsaBR on the sialoglycan microarray, we asked if HsaBR could be a replacement for MAL I and MAH, conventional lectins for this class of probes (SGRP3). In an experiment to compare Siaa2-3-binding preferences of Biotin-HsaBR, Biotin-MAL and Biotin-MAH, HsaBR showed significantly pronounced Siaa2-3-binding ability regardless of Sia modifications (O-acetylation, O-sulfation), or glycan structures (disaccharides, trisaccharides, oligosaccharides) (Suppl Fig S6A) . Taken together with the glycan array data, we chose biotinylated HsaBR as our SGRP 3 probe (SGRP3 Hsa )and and its non-binding variant HsaBR (R340E) as the nonbinding control (SGRP3 Hsa NB) to characterize a2-3Sia-binding through various assays such as ELISA, Western Blotting, FACS and histochemistry, discussed below. SGRP4 MHV as a probe for 4-OAc-Sias. A major contributor to mammalian sialoglycan diversity is O-acetylation, substituting the sialic acid hydroxyl groups at C4, C7, C8, and/or C9 (23, 24) .

The presence or absence of these O-acetyl moieties can block or promote binding of cellular and microbial lectins, and their regulation through sialate-O-acetylesterases (SOAEs) and sialate-Otransferases (SOATs) act as the molecular switches to control several cellular functions and interactions (25, 26) . In contrast to O-acetylation at C7 or C9-OH, the occurrence of 4-O-acetylated Sia and its structural and functional significance have yet to be explored in much detail. In general, 4-OAc-Sias have been difficult to study even by chemical methods, due to variable expression or absence in many animal species, dynamic occurrence in pathological conditions, resistance to conventional sialidases, lability to acidic conditions (27) and masking of Sias from detection by some lectins. Equine erythrocytes, a2-macroglobulins and sera were used to study 4-OAc-"HD3"reactive antibodies due to their high 4-O-acetyl-N-acetylneuraminic acid (Neu4,5Ac2) content (30-50% of total Sias) (28) . Guinea pigs serve as another common source of mammalian 4-OAc-Sias.

Neu4,5Ac2 comprises a considerable share in serum (30% of all Sias) and liver (10% of all Sias) Sias in guinea pig, besides traces of 4-O-acetyl-N-glycolylneuraminic acid (Neu5Gc4Ac) in serum (29) .

In humans, 4-OAc has been reported in tumor-associated antigens of colon cancers, melanomas and gastric cancers using "HD" antigen specific antibodies, for example a chicken antibody specific to Neu5Gc4Ac-lactosylceramide (4-OAc-HD3) recognized Neu5Gc4Ac in GM3 ganglioside fractions of human colon cancer tissues (30) . Similar 4-OAc-HD3-reactive HD antibodies have also been reported in sera of patients suffering from malignancies and liver diseases (31) . Two chicken MAbs HU/Ch2-7 and HU/Ch6-1 reacted with Neu5Gc4Ac in HD3 antigens (32) . These MAbs, specific for individual glycan structure were a major tool for detection of 4-OAc in gangliosides or glycoproteins. Despite frequent reports on heterogenous 4-OAc in HD antigens in human cancers, there has not been a reliable conventional probe for in situ detection of this entire class of sialoglycans.

Previously, a sialic acid-binding lectin with specificity for O-acetyl Sia was purified from the hemolymph of the California coastal crab Cancer antennarius, which was more precise than other known lectins from horseshoe crab (Limulus Polyphemus) and slug (Limax flavus) but it also showed affinity towards 9-O-acetyl in addition to 4-O-acetyl Sias (33) 

Tritrichomonas foetus, a parasitic protozoan that causes abortion in cows, was reported to react preferentially with Neu4,5Ac2 over de-O-acetylated Sias, and agglutinated equine erythrocytes containing Neu4,5Ac2 efficiently, but its preferences were also not exclusive for 4-O acetylated Sias (34) .

In general, O-acetylation of Sias can be a major receptor determinant for some viruses.

Among the first viruses shown to initiate infections via O-Ac-Sias were the influenza C viruses, human coronavirus OC43, Bovine Coronaviruses BCoV and porcine encephalomyelitis virus (PToV), but none of them exhibited binding of Neu4,5Ac2 (35) (36) (37) (38) (39) . Infectious salmon anemia virus (ISAV), the causative agent of infections in Atlantic salmons showed specificity for, and hydrolysis of 4-OAcetylatedAc-Sias (40) . ISAV preferentially de-O-acetylated free and glycosidically bound Neu4,5Ac2 and showed lower and no hydrolysis for free and bound Neu5,9Ac2 respectively. ISAV exhibited hydrolysis for both Neu4,5Ac2 and Neu4Ac5Gc at comparable efficacy, which was a significant advantage over known 4-OAc-Sia-binding molecules but it's affinity for free Neu5,9Ac2 although lower than influenza C virus (40) , restricted possibilities to derive a comprehensive probe for 4-OOAc-Sias.

Murine coronavirus mouse hepatitis virus (MHV-stain S) expresses a hemagglutininesterase that exhibits comparable sialate-4-O-Acetylesterase enzymatic activity to that of ISAV (41) . Unlike comparable esterases from other sources, MHV-S HE protein specifically de-Oacetylates Neu4,5Ac2 but not Neu5,9Ac2, and converts glycosidically-bound Neu4,5Ac2-rich glycoproteins from horse and guinea pigs to Neu5Ac (41). MHV-S was able to hydrolyze acetyl esters from free as well as glycosidically-linked Neu4,5Ac2. Interestingly, MHV-A59 and several other MHV strains do not express a HE (42) (43) (44) . Previously, the MHV-S HE ectodomain, released from HE-Fc by thrombin-cleavage, was reported to exhibit proper sialate-4-O-acetylesterase activity when assayed for substrate specificity with a synthetic di-O-acetylated Sia (4,9-di-Oacetyl-N-acetylneuraminic acid a-methylglycoside, aNeu4,5,9Ac 3 2Me) (45) .

Considering MHV-S HE as a useful tool for the histological detection of Neu4,5Ac2, our collaborators had previously expressed the esterase-inactive MHV-S HE ectodomain as a fusion protein with a C-terminal Fc domain of human IgG1 and investigated Neu4,5Ac2 distribution in human and mouse tissues (46) . In another study, we further modified the virolectin by fusing MHV-S-HE ectodomain-Fc to a hexahistidine (His6) sequence and detected high expressions of 4-OAc-Sias in horse and guinea pig respiratory tract tissues than mouse where it was mostly localized in gastrointestinal tract. 4-OAc-Sias were also found in a small number of cells within the duck, dog, and ferret respiratory tissues screened but not so far in the tissues of humans or pigs (47) .

To derive a stable 4-OAc-Sia binding probe, we expressed the MHV-S-HE esterase inactive ectodomain (S45A), and the nonbinding mutant MHV-S-HE (F212A), as fusion proteins with the C-terminal Fc domain of human IgG1, along with Avi-tag for permanent biotinylation (Suppl Fig S3) . Sia-binding and nonbinding proteins MHV-S-HE protein probes were biotinylated using manufacturer's protocol and tested for their specificity for 4-OAc-Sias on sialoglycan microarray. As anticipated, biotinylated Sia-binding MHV-S-HE (S45A) exhibited very specific recognition of towards 4-OAc-Sias while the nonbinding mutant MHS-S HE (F212A) did not show any binding with any sialylated or non-sialylated glycan on the microarray, confirming its suitability as a non-binding control ( Figure 1; Suppl Fig S4) . Biotinylated MHV-S-HE (S45A) binds exclusively to Neu4,5Ac2α3Galβ3GalNAcαR1, Neu4,5Ac2α3Galβ3GalNAcβR1, Neu4,5Ac2α3Galβ3GlcNAcαR1, Neu4,5Ac2α3Galβ3GlcNAcβR1, Neu4,5Ac2α3Galβ4GlcβR1, Neu4,5Ac2α3Galβ4GlcNAcβR1 and Neu4,5Ac2α3Galβ4GlcNAcβ3Galβ4GlcβR1 ( Figure 1 ).

Despite such high specificity and avidity for Neu4,5Ac2, MHV-S-HE (S45A) did not show any binding of 4-OAc-Neu5Gc-glycans on the array (Fig 1) . Currently, the sialoglycan microarray does not include α2-6-linked 4-OAc-Sias (Neu5Ac or Neu5Gc), hence the binding of MHV-S-HE a2-6-linked 4-OAc-Sias is not discussed here.

Considering the rare occurrence of Neu5Gc4Ac and limited knowledge about 4-OAc-Siarecognizing proteins, MHV-S HE-derived fusion proteins provide the most useful probes for in situ detection of 4-OAc-Sias, represented mostly by Neu4,5Ac2. Given its exclusive preference for 4-OAcetylated-Sias, the biotinylated MHV-S-HE esterase inactive ectodomain appears to be the best probe for this class of sialoglycans (SGRP4 MHV and SGRP4 MHV NB) and demonstrate its utility through ELISA, Western blotting, FACS and histochemistry in this article. We expect that SGRP4 MHV will facilitate research on functional significance of 4-OAc-Sias, help finding more comprehensive 4-OAc-Sia binding proteins and will allow us to seek an improved version of SGRP4 with recognition of both Neu4,5Ac2 and Neu5Gc4Ac.

SGRP5 IgY recognizes all Neu5Gc-terminated glycans. Humans are genetically defective in synthesizing the common mammalian Sia-Neu5Gc but can metabolically incorporate small amounts of this Sia from dietary sources into glycoproteins and glycolipids of human tumors, fetuses and some normal tissues (48). Neu5Gc derived from dietary sources has been observed in breast, ovarian, prostate, colon and lung cancers. Thus, there is need for sensitive and specific detection of Neu5Gc in human tissues and biotherapeutic products. Previously a number of different monoclonal antibodies against Neu5Gc have been reported which recognized Neu5Gc only in the context of particular underlying sequences, but those generally lack the ability to detect Neu5Gc on other structurally related or unrelated glycans (49) (50) (51) (52) (53) (54) (55) .

We could not find a microbial Sia-binding protein that is completely specific for Neu5Gc, as there is always some cross-reactivity with few Neu5Ac glycans (51) (52) (53) . Previously, we had improved the specificity and reduced background cross reactivity of a chicken polyclonal anti-Neu5Gc-glycan IgY by modifying the affinity purification procedures (56) . Since then, this chicken anti-Neu5Gc IgY has been the only available probe for comprehensive in situ Neu5Gcglycan detection.

To explore alternative Neu5Gc-specific probe from microbial sources, we previously reported Neu5Gc-binding preferences of subtilase cytotoxin (SubAB), an AB5 toxin secreted by Shiga toxigenic Escherichia coli (STEC) (10) . SubB, the B5 subunits of STEC AB5 toxin, exhibits strong preference for Neu5Gc-terminating glycans and serves as key structural basis of STEC's specificity towards Neu5Gc. SubB showed 20-fold less binding to Neu5Ac; over 30-fold less if the Neu5Gc linkage was changed from α2-3 to α2-6. Neu5Gc-binding by SubB suggested that a more selective diagnostic tool for Neu5Gc detection can be derived from the native protein. Day and colleagues, using molecular modeling and site directed mutations, managed to reduce the α2-3 to α2-6-linkage preference, while maintaining or enhancing the selectivity of SubB for Neu5Gc over Neu5Ac (57) . This SubB analog, SubB2M (SubBΔS106/ΔT107 mutant) did display improved specificity towards Neu5Gc, bound to α2-6-linked-Neu5Gc and could discriminate Neu5Gc-over Neu5Ac-glycoconjugates in glycan microarrays, surface plasmon resonance and ELISA assays. SubB2M also showed promising diagnostic properties in detecting Neu5Gcglycans in early stages of ovarian cancer, and in late-stage diseases which express high levels of Neu5Gc-glycans (58) .

Considering the promising Neu5Gc-binding properties of SubB proteins, we attempted to derive a comprehensive probe for Neu5Gc-glycans from SubB and tested His6-tagged versions of the reported SubB proteins including SubB, SubB2M and SubB2M-nonbinding mutant (SubB2M, S12A) on the glycan array. SubB2M exhibited significantly improved recognition of Neu5Gcglycans compared to the native SubB, while the nonbinding mutant of Sub2M did not show any binding with glycans on the array (Suppl Fig S7) . While we were able to reproduce the higher Neu5Gc preferences of Sub2M over native SubB, (59) . our sialoglycan microarray data suggested that despite having promising Neu5Gc-binding properties, the Sub2M lacked the scope and robustness of Neu5Gc binding abilities of chicken anti-Neu5Gc IgY (Suppl Fig S7) .

Considering results obtained from the Neu5Gc-binding molecules discussed or tested above, it can be inferred that there is no contemporary molecule better than the affinity-purified chicken polyclonal anti-Neu5Gc-IgY to detect a broader range of Neu5Gc-glycans. Hence, we selected chicken polyclonal specific anti-Neu5Gc-IgY as SGRP5 and biotinylated this along with its nonbinding control IgY (from non-immunized chickens) as the final set of SGRP5 IgY (Suppl Fig S4) . The utility of chicken Neu5Gc-IgY as SGRP5 IgY in general lab-used methods including ELISA, Western Blotting, FACS and histochemistry is discussed in an earlier article, and the results obtained here confirmed its Neu5Gc-specificity as previously reported (56, 60) . In a long run, it is necessary to identify a monoclonal IgY that can detect all forms of Neu5Gc-sialoglycans.

SGRP6 SNA recognizes all α2-6-Sias. Unlike bacteria, some viruses that cause upper respiratory infections such as human influenza A, B viruses, and human coronavirus OC43 exhibit preferential affinity towards a2-6Sias, which are abundant in the upper airway epithelial brush border in humans (61, 62) . Influenza viral haemagglutinins (HA) are the major glycoproteins that allow the recognition of cells in the upper respiratory tract or erythrocytes by binding to α2-6Sias, and this property makes them potential candidates for α2-6Sias-binding probes. We investigated a range of viral HAs in the form of HA-Fc fusion proteins (soluble HA fused to human IgG1 Fc) for their sialoglycan-binding specificity using the glycan microarray (Suppl. Fig S8) . Among the tested HA-Fc fusion proteins, Cali09 HA-Fc derived from California/04/2009 H1N1 showed selective binding to a2-6-linked Sias, most prominently with Neu5Acα6Galβ4GlcNAcβR5, followed by Neu5Acα6Galβ4GlcNAcβR1 and Neu5,9Ac2α6Galβ4GlcNAcβR1. Despite strong preferences for these a2-6Sias, none showed binding with a full range of α2-6Sias, specially a2-6Neu5Gc

glycans. The failure of Cali09-HA-Fc to recognize a number of a2-6-linked sialosides, and its binding to a few a2-3 Sia-linked sialosides questioned its suitability as a probe for α2-6linked

Sias (Suppl. Fig S8) . Aichi68-HA-Fc derived from the hemagglutinin of Aichi/2/1968 H3N2 strain also lacked robustness and specificity showing indiscriminate binding towards a number of α2-6 and α2-3 Sias (Suppl. Fig S8) . Surprisingly one candidate, PR8 HA-Fc derived from Influenza strain A/Puerto Rico/8/1934 (PR8 H1N1)), even showed prominent binding of α2-3-sialylated glycans instead of α2-6Sias (Suppl. Fig S8) . Among other tested viral haemagglutinins, SC18 HA-Fc derived from influenza A H1N1 (A/SouthCarolina/1/18) exhibited selective binding to a few α2-6 Sias such as Neu5Acα6Galβ4GlcNAcβR5 and Neu5Acα6Galβ4GlcNAcβR1 while another virolectin Mem-HA-Fc from influenza A H1N1 (A/Memphis/1/1987) bound to a2-3Sias and α2-6Sias without any strong preference for either linkage (Suppl. Fig S8) . Taken together, it can be inferred that the viral haemagglutinins tested exhibited promising specificity towards α2-6Sias but lacked the robustness and binding dynamics required for a probe. Our results and observations appear true for several other viral hemagglutinins not included in this study (63) .

As an alternative α2-6Sia-specific microbial probe, we reviewed the α2-6Sia-binding properties of a recombinant lectin (PSL) from the mushroom Polyporus squamosus that was reported for its high affinity binding with Neu5Acα2-6Galb4GlcNAc (64, 65) . However, PSL showed a high order preference towards α2-6 over α2-3Sias but bound exclusively to N-linked recognizing Neu5Acα6GalNAc on serine/threonine-linked glycoproteins, we did not experimentally investigate this molecule further as an a2-6Sia-specific probe.

As an α 2-6Sia-binding alternative from mammals, we considered the well-characterized vertebrate sialic acid-dependent adhesion molecule CD22/Siglec-2 which is a member of the immunoglobulin superfamily that is expressed by B lymphocytes and binds specifically to Neu5Aca6Galb4GlcNAc (66) (67) (68) (69) (70) . hCD22-Fc (human CD22 fused with the Fc region of human IgG1) showed high affinity for a few a2-6Sias on microarray (Suppl Fig S9) , but lacked the avidity required for a probe, particularly for a2-6-linked Neu5Gc. With a possibility to characterize 2 SGRP6 candidates; one specific for a2-6Neu5Ac and the other for a2-6Neu5Gc, we tried exploiting the evolutionary derived strong preference of mouse siglec-2 (mCD22) for a2-6Neu5Gc. mCD22-hFc showed exclusive binding towards a2-6Sias, but preferred Neu5Gc in general (Suppl Fig S9) . Interestingly, 9-O-acetylation completely aborted hCD22's binding to a2-6Neu5Ac (Suppl. Fig S9) but did not affect mCD22 binding to a2-6Sias. Nevertheless, the relatively poor avidity and inability of hCD22 to recognize O-Ac-substitution in a2-6Neu5Ac, and the non-specificity of mCD22 binding a2-3 sialyl-LNnT glycan (Neu5Gca3Galb4GlcNAcb3Galb4Glc) underlined their incompetency as an ideal a2-6Siabinding probes, even in combination (Suppl Fig S9) .

Among other molecules, we also analyzed the adhesin of non-typeable Haemophilus influenzae which was reported for high affinity towards a2-6-linked Neu5Ac (71). According to this study, HMW2 bound with high affinity to a2-6-linked Neu5Ac such as Neu5Aca6Galb4GlcNAc (a2-6-sialyllactosamine) and could discriminate it from a2-3Sias (<120-fold lesser binding with a2-3 Siallylactosamine).-linked siallylactosamine). HMW2 indeed showed appreciable preference for the a2-6 over the a2-3-linkage but was not able to recognize α2-6Neu5Gc, disqualifying it from consideration as a comprehensive probe for α2-6Sias. In the absence of an evolutionarily derived microbial protein as a dynamic probe for α2-6Sias, we considered whether SNA (Sambucus nigra or elderberry bark lectin) is still the best available probe for α2-6Sias.

SNA exhibits high preference for the terminal Neu5Aca6Gal/GalNAc sequences in both N-linked and O-linked glycans (72) . Due to its ability to discriminate Siaa6Gal/GalNAc from Siaα2-3Gal/GalNAc and ubiquitous binding to Neu5Ac/Gc with/without O-Ac substitutions, SNA has been the standard probe for studying α2-6Sias. Using Vector lab's Biotin-SNA, we investigated SNA's Sia-binding efficiency in sialoglycan microarray and observed very high preference towards α2-6Sias for both Neu5Ac and Neu5Gc and no measurable binding to α2-3Sias (Fig 1) . Interestingly, the O-acetyl substitutions that were a major concern for hCD22, mCD22, viral hemagglutinins and HMW2, did not hinder SNA's binding to α2-6Sias. Apart from its binding to 6-O-sulfated Galb4GlcNAc (73), SNA displayed an exclusive preference for α2-6Sias in disaccharides, trisaccharides and oligosaccharides in Asn or Ser/Thr-linked glycans. There appears to be no better molecule than SNA to probe α2-6Sias, hence we selected Biotin-SNA as SGRP6 (SGRP6 SNA ) for this study. SGRP6 SNA is the exception to the set of SGRPs in not having an internal control of specificity. We characterized SGRP6 SNA as α2-6Sia-probe without any nonbinding variant in routine lab assay methods in this article. are not commonly reported in natural glycans because of their instability. During synthesis, the primary attachment site of O-acetyl groups was exclusively to the hydroxyl at C-7 of Sias, and the ester group migrates from C-7 to C-9 (77) . A hypothesis was proposed that SOAT enzyme would effectively be a 7-O-acetyltransferase incorporating O-acetyl groups primarily at C-7 of sialic acids, followed by their migration to the primary hydroxyl group at C-9 and further transfer of the acetyl residue to C-7, resulting in di-and tri-O-acetylated species (78) . This suggests that in nature 7-OAc will be represented as 7,9-diOAc or 7,8,9-triOAc, but largely as 7,9-diOAc in mammalian sialoglycans. Considering, there is no stable 7-OAc, there may not be a true 7-OAc-Sia-binding protein, we defined specificities of SGRP7 to 7,9-diOAc-Sias. 7/9di,9-diOAc has traditionally been studied in bovine submaxillary mucin, where the amount of 7-OAc-and 7,9-diOAc-Sias combined is almost twice of 9-mono-OAc-Sias (46) .

We also reviewed the sialoglycan specificity of lectins and microbial proteins, previously reported for their binding to 7,9-diOAc-Sias. Lectins from Cancer antennarius, Achatina fulica and Tritichomonas foetus showed higher preferences for 9-OAc and somewhat to 4-OAc but negligible to poor affinities for 7,9-diOAc-Sias (33, 34, 79) . Viruses exhibit prominent binding to O-Ac-Sias but most show either 9-OAc preference (Influenza C viruses, human coronavirus OC43, porcine encephalomyelitis virus) or 4-OAc preference (Infectious salmon anemia virus, Puffinosis virus, mouse hepatitis virus strains-S, DVIM, JHM) binding over 7,9-diOAc (35-40, 46, 80, 81) .

The hemagglutinin esterases from bovine toroviruses (BTOV-B150, BToV-Breda), bovine coronaviruses (strains; Mebus and Lun) and equine coronavirus (ECoV-NC99) preferentially cleave 7,9-diOAc substrates over mono 4-or 9-OAc-substrates (46, 82) . Bovine viruses exhibit selective binding towards 7,9-diOAc, particularly BCoV-Mebus having relatively pronounced preferences towards 7,9-diOAc variants of both Neu5Gc and Neu5Ac, but lower preferences for 9-OAcs (46) . It is interesting that BCoV esterase selectively removes all 9-OAc residues in 7,9-diOAc-Sias in BSM, leaving 7-OAc attached. The residual 7-OAc residues do not attract binding of BCoV anymore, demonstrating that Sia 9-O-acetylation is a strict requirement and that mono 7-OAc-Sias do not serve as ligands (46) . The S protein, another hemagglutinin in BCoV, showed high specificity exclusively for 9-OAc-Sias with no preference for 7-OAc and this raises possibility that HE is the only receptor-binding protein for 7,9-di-Ac in BCoV-Mebus (83, 84) .

Since BCoV-Mebus-HE is the best characterized for 7,9-diOAc-Sia specificities, we expressed its esterase inactive mutant (BCoV-Mebus-HE S40A) and corresponding non-binding mutant (BCoV-Mebus-HE F211A), each fused to human IgG-Fc followed by a His6-tag and an

Avi-tag. Both proteins were biotinylated with an Avi-tag and were tested for their sialoglycan preferences on sialoglycan microarray (Fig 1, Suppl Fig S4) . As observed, the nonbinder mutant does not show any binding with any sialylated or non-sialylated glycans in the array while the Siabinding molecule BCoV-Mebus-HE S40A exhibited some affinity for 9-OAc-Sias (Fig 1) , agreeing with its Sia-binding pattern on sialoglycan microarray reported previously (46) . However, similarly encouraging as the BCoV-Mebus-HE, S40A did not exhibit any binding to 4-OAc, most 9-OAc-Sias and non-acetylated sialyloligosaccharides, the sialoglycan microarray did not contain 7/9diOAc,9-diOAc-Sias, so it is not known whether the protein binds that form.

SGRP8 TeT binds to major class of (a2- (97) and Helicobacter pylori recognizes GD2, GD1a and GD1b by its sialic acid-binding adhesin (SabA) (98) . In agreement with high affinity for single ganglioside as observed in Vibrio cholerae (GM1), the majority of gut infecting bacteria and viruses exhibit binding with a specific sialoglycan structure, and their affinity cannot be generalized for range of disialyloligosaccharide sequences.

Clostridium tetani and Clostridium botulinum, respectively, and share significant structural and functional similarity (99) . Not only BoT (serotypes A to G) and TeT exhibit affinities for similar di and oligosialogangliosides but also share significant sequence homology. In both BoT and TeT, 150Kda single chain can be cleaved in to 50Kda N-terminal light chain and 100Kda C-terminal heavy chain. The HC fragment plays the primary role in receptor binding and can be further cleaved into 50Kda N-terminal fragment (HN) and 50Kda C-terminal fragment (HC). HC domain or HCR is characterized by the amino acid sequence homology among BoTs and TeT, which suggests that a conserved amino acid motif of in this domain may define a common carbohydrate recognition site. Since both BoT and TeT possess comparable binding specificity for gangliosides, we preferred TeT to investigate its potential for a comprehensive disialyl linkage recognizing probe. Selection of TeT over BoT was also based on detailed reports on TeT binding to gangliosides (100) (101) (102) (103) , and feasibility to select single serotype of TeT than BoT that has multiple

serotypes. An optimal receptor-binding domain (residues 1105 -1315) from TeT-HCR was expressed as SNAPf-His6 fusion in the pGEX-3X vector in a bacterial expression system along with its mutants TeT-HCR R1226L, TeT-HCR W1289A, and TeT-HCR R1226L/W1289A (Suppl Fig S3 & S10) . Expressed proteins were biotinylated by SNAP-Biotin chemistry as described in experimental procedures and tested for their sialoglycan affinity in microarray (Fig 1, Suppl Fig   S4 , S10). TeT has been shown to specifically bind gangliosides of the G1b series, GD1b or GT1b.

In accordance with published report (102), TeT-HCR bound with a range of sialogangliosides including monosialylated GM1a, fucosyl-GM1 and oligosialylated GD1a, GD3, GT3 (Suppl Fig   S10) . The high affinity of TeT-HCR for GM1 and Fuc GM1 questioned its candidacy as di-Sia linkage specific probe. Single mutant; TeT-HCR R1226L and double mutant TeT-HCR R1226L/W1289A didn't bind with any glycans on array, suggesting the significance of arginine residue at 1226 position in sialoglycan identification (Suppl Fig S4 and S10 ). Another single mutant TeT-HCR W1289A showed appreciable enhancement in affinity towards GD3, GT3 while loss in binding towards monosialylated and asialylated glycans on array (Suppl Fig S10) . With respect to TeT-HCR (native protein), the tryptophan mutant TeT-HCR W1289A had pronounced specificity towards disialogangliosides structures particularly Neu5Acα8Neu5Acα3Galβ4GlcβR1, Neu5Acα8Neu5Acα3Galβ4GlcβR4, Neu5Acα8Neu5Acα8Neu5Acα3Galβ4GlcβR4, and Neu5,9Ac2α8Neu5Acα3Galβ4GlcβR1 (Suppl Fig S10) . However, we, we noticed that TeT-HCR W1289A exhibited some minor binding with monosialogangliosides on the array but based on its high affinity for the range of a2-8-linked disialyl oligosaccharides and lack of other available options (MAbs, plant lectins, siglecs, viral, bacterial proteins) to derive a more potent probe for this class, we selected biotinylated TeT-HCR W1289A as SGRP8 (SGRP8 TeT ). We selected the double mutant; Biotinylated TeT-HCR R1226L/W1289A (SGRP8 TeT NB) as a nonbinding control of SGRP8 TeT due to its complete loss of binding for any glycans on array. The broad specificity of several bacterial toxin including TeT-HCR towards GM1, GD3, GT3 and GQ series of glycans could be related with evolutionary preference to bind with most available ligands in their neural niche. This nonexclusive binding with multiple ligands by toxins might have advantage for the microbes but reduces our possibility to derive a molecule with probe like robustness and dynamic specificity. Here, we present that site-specific modifications could improve the binding range in otherwise 'nonspecific' probe candidates and characterize SGRP8 TeT as a2-8-disiaoligosaccharide binding probe through general laboratory methods later in this report. showed affinity for 9-OAc and was used to demonstrate the presence of tumor-associated 9-OAc-GD3 on human melanoma cells (33) . Cancer antennarius lectin also showed significant affinity for Neu4,5Ac2, and didn't show affinity for 9-OAc. AchatininH, a lectin from the hemolymph of African land snail Achatina fulica did not bind to Neu4,5Ac2, but failed to exhibit probe-like preference for a number of 9-OAc-Sias (105) . Another lectin from protozoan, Tritichomonas foetus showed promising affinities for 9-OAc-Sias but also bound to de-O-acetylated Sias relatively high affinity, confirming its unsuitability as a probe (34).

9-OAc-Sia-binding specific influenza C virus hemagglutinin esterase (Inf-CHE) was previously utilized as whole virions or recombinant protein for assessing a wide spectrum of sialoglycoconjugates like mucins, serum glycoproteins or gangliosides containing naturally or synthetically O-acetylated sialic acids (106) . The influenza C virus hemagglutinin-esterase is a membrane-bound glycoprotein that binds specifically to 9-O-acetylated sialic acids (hemagglutinin activity) and then hydrolyzes the O-acetyl group (receptor-destroying activity).

Inf-CHE can specifically cleave O-acetyl groups from Neu5,9Ac2 but not from 7-O-acetyl-Nacetylneuraminic acid (Neu5,7Ac2), and very slowly from Neu4,5Ac2 (107) . Previously, we demonstrated that inactivation of Inf-CHE esterase by treatment of serine esterase inhibitor di-isopropyl fluorophosphate (DFP) resulted into a stable and irreversible binding with 9-OAc-Sias (106) . However, using the whole virion as a probe was complicated due to variations in purity and stability of preparations, poor reproducibility, high nonspecific background, and lack of linearity in response. To avoid these limitations, we had replaced Inf-C virions with a soluble and recombinant chimeric molecule composed of the extracellular domain of Inf-CHE fused to the Fc region of human IgG1 (CHE-Fc). DFP inactivation of CHE-Fc stabilized the hemagglutinin activity and yielded a probe CHE-FcD that was more specific for 9-OAc-Sias than the whole Inf-C virion (108, 109) . CHE-FcD provided a better alternative but did not qualify as a standard probe for 9-OAc-Sias due to selective preference for Neu5,9Ac2 over Neu9Ac5Gc glycans, nonspecific binding to Neu5,7Ac2 and hazards related to use of DFP (Supp. Fig S11) , (40) .

In order to derive a better probe for 9-OAc-Sias, we reviewed other O-Ac-esterases from OAc-Sias and demonstrated its applicability to revealing the OAc-Sia distribution in human and animal tissues and cell lines (46, 47) .

We expressed 9-OAc binding protein (PToV-HE-Fc, S46A) and nonbinding protein (PToV-HE-Fc, F271A) fused to human IgG-Fc followed by a His6 tag and an Avi-tag (Suppl. Fig   S3) . Both binding and nonbinding proteins were biotinylated using the Avi-tag and investigated for their affinities in a sialoglycan microarray. The esterase-inactive probe; PToV-HE-Fc (S46A) bound exclusively with 9-OAc-Sias including Neu5Ac and Neu5Gc, while hemagglutinin inactive nonbinding PToV-HE-Fc (F271A) did not show affinity towards any sialylated or nonsialylated glycans on array (Fig 1, Suppl Fig S4) . suggests high variance in Sia diversity among animals which would be interesting to detect with SGRPs. We emphasized on minimal loss of heat and pH labile O-Acs during assays and modified the procedures accordingly.

SGRP1 YenB exhibits Sia specific binding to all mammalian sera.

As results summarized in Fig 2 suggest , SGRP1 YenB exhibits comparable affinity to all sera, indicating its broad range of Sia specificities. In accordance with the observation from glycan array ( Fig. 1) , SGRP1 YenB exhibits strong binding towards sera whether it was Neu5Gc rich (mouse, goat)

or Neu5Ac abundant (human, rat and Cmah -/mouse). Further, high proportions of Sia modifications such as 9-OAc substitutions (rat, rabbit and Cmah -/mouse) and more prominently, 4-OAc substitutions (guinea pig and horse serum) didn't inhibit SGRP1 YenB 's binding to serum sialoglycans ( Fig. 2A) . Sialoglycan microarray (Fig. 1) confirms SGRP1 YenB 's strong binding towards sialoglycans that may directly be responsible for its binding to immobilized sera, but to exclude the potential contribution of serum protein interactions with SGRP1 YenB from our observations, we performed binding assays with sera after partial and complete Sia depletion. Mild periodate oxidation of sera followed by borohydride reduction generates side-chain truncated-Sias with a terminal hydroxyl at 7 th carbon. SGRP1 YenB showed significantly reduced binding to periodate oxidized sera that was proportional to the loss of desired Sia ligands after the truncation (Supp. Fig S12A) . A question remained as to whether the residual binding of SGRP1 YenB to sera, observed even after periodate treatments were due to SGRP1 YenB interaction with non-sialylated structures in serum, or the O-acetyl substitutions protecting Sias from complete oxidation. When O-acetyl esters were removed by mild base treatment before periodate oxidation, the residual SGRP1 YenB binding was completely abolished, thereby excluding the role of protein-protein interaction in SGRP1 YenB 's binding to mammalian sera (Supp. Fig S12A) . In the same experiment, base treatment without periodate oxidation did not significantly influence SGRP1 YenB binding to sera, confirming the probe's unbiased preference for Sias as seen in glycan array also (Fig 1) .

Significantly, the nonbinding variant of the probe, SGRP1 YenB did not show any binding with any serum at all tested concentrations, as expected (Fig 2A) .

SGRP2 PltB exhibits Neu5Ac-specific binding to mammalian sera. SGRP2 PltB binds to Neu5Ac and its derivatives that constitute a major fraction of Sia population in mammalian sera.

Accordingly, SGRP2 PltB exhibited binding to all serum types tested in a concentration dependent manner ( Fig 2B) . However, SGRP2 PltB exhibits an interesting pattern of binding towards Neu5Gc rich mouse serum vs Neu5Ac rich sera, especially human and Cmah -/mouse sera. The non-binding mutant SGRP2 PltB NB failed to bind serum from any animal source. Binding assays with mild base and periodate-treated sera confirmed that SGRP2 PltB 's binding towards serum was exclusively to

Sia and was devoid of nonspecific interactions (Suppl Fig. S12B ). The SGRP2 PltB also exhibited residual binding after periodate oxidation that were further reduced with prior base treatments, but base treatment alone did not noticeably influence the SGRP2 PltB binding to sera.

SGRP3 Hsa exhibits a2-3Sia-specific binding to mammalian sera.

SGRP3 Hsa is specific towards Sias linked to underlying glycans with a2-3-linkage that coexist with a2-6Sias and a2-8-linked Sias in cells, tissues, and other biological samples. Among the sera employed to investigate SGRP3 Hsa binding towards a2-3-linked Sias in complex biological samples, SGRP3 Hsa bound all sera in a concentration dependent manner. In a different experiment to test Sia-specific binding of SGRP3 Hsa to serum, the probe exhibited sera binding directly proportionate to their Sia constituents (Suppl Fig S12C) , excluding non-specific interaction with nonsialylated structures in serum. Collectively, the results demonstrate SGRP3 Hsa 's indiscriminate binding to a2-3 Sia in serum, irrespective of O-acetylation, Neu5Ac or Neu5Gc, a finding that agrees with our observations from sialoglycan microarray (Fig 1) . SGRP3 Hsa NB, the nonbinding version of SGRP3 Hsa showed no binding with any serum at tested concentrations ( Fig 2C) .

SGRP4 MHV exhibits 4-OAc-Sia-specific binding to mammalian sera.

SGRP4 MHV represents a probe for an exclusive class of 4-O-acetylated sialoglycans, which show a high abundance in the blood components and tissues of certain animals. In our collection of sera, 4-OAc is represented by guinea pig and horse (38.7% and 32.4% of total Sia content respectively-Suppl. Table 1 ) and accordingly SGRP4 MHV exhibited strong affinity towards these sera (Fig 2D) .

The negligible binding of SGRP4 MHV to other sera suggests that its specific binding to guinea pig and horse serum was due it's binding to 4-OAc-Sias exclusively found in these samples.

Importantly, SGRP4 MHV exhibited no binding to serum rich in 9-OAcs (Cmah -/-, rat and rabbit).

confirming its ability to detect 4-OAcs over 9-OAcs. In similar experiment, SGRP4 MHV NB didn't bind to any serum at tested concentrations, confirming its utility as nonbinding control. In another qualitative approach to test SGRP4 MHV 's specificity towards 4-OAcs, its binding was assessed with sera, pretreated with mild base and periodate. Periodate treatment did not have much effect on SGRP4 MHV 's binding towards guinea pig and horse serum, whereas base treatment and base treatment followed by periodate oxidation completely blocked Sia detection (Suppl Fig S12D) .

These results, along with sialoglycan glycan microarray confirms that even in complex biological samples like serum, SGRP4 MHV binds only to 4OAcSias SGRP5 IgY exhibits Neu5Gc-specific binding to mammalian sera.

Similar to SGRP4 MHV , sera binding experiment for SGRP5 IgY had internal indicators of probe' specificity. While 5N-glycolylated Sias (Neu5Gc) are the major component of Sia diversity in mammals, Neu5Gc is absent from humans due to loss of functional Cmah, and also in Cmah -/mice. The serum binding assay (Fig. 2E ) exhibits that SGRP5 IgY showed very strong affinity for the WT mouse serum, and also binding to all sera except human and Cmah -/mouse. Significantly SGRP5 IgY showed the reverse binding pattern to that was observed with SGRP2 PltB (Fig 2B) ,

suggesting an approach to double-check the specificity of such complimentary probes.

SGRP5 IgY NB didn't bind any serum tested in similar experiment, as anticipated. A binding assay with base-and periodate-treated sera supported the specificity of SGRP5 IgY , as removal of OAc esters did not affect its binding to serum, while removal of Sias abolished binding (Suppl Fig   S12E) .

SGRP6 SNA exhibits a2-6 specific binding to mammalian sera.

SGRP6 SNA exhibits strong and general binding with all mammalian sera in binding experiment, suggesting its robustness as a2-6Sia-recognition probe. As observed in glycan array (Fig1), SGRP6 SNA does not discriminate between a2-6Neu5Ac and a2-6Neu5Gc, with or without OAc esters. Similarly, the serum binding data (Fig 2F) shows binding of SGRP6 SNA to mouse, rabbit, guinea pig, human or Cmah -/mouse sera which contain Neu5Gc, Neu5Ac & Neu5,9Ac2, Neu4,5Ac2, Neu5Ac, Neu5Ac and Neu5,9Ac2 respectively. SGRP6 SNA has traditionally been used as a2-6 Sia recognizing probe, and our binding experiment with periodate oxidized serum confirms that SGRP6 SNA binds to sera in Sia specific manner and does not bind serum proteins (Suppl Fig S12F) .

SGRP7 BCoV exhibited insignificant binding to tested mammalian sera, likely due to very strong preference towards 7,9 diOAcSias, absent in these sera ( Fig 2G) . The probe does possess inconsistent and minor binding preferences towards 9-OAc-Sias but those were not detected in the sera sialoglycans. To confirm SGRP7 BCoV 's recognition of 7, 9-diOAc-Sias, we performed binding experiments with immobilized BSM, enriched in di-and tri-OAc-sialoglycans. As anticipated, SGRP7 BCoV showed dose-dependent binding patterns to BSM, while the nonbinding mutant SGRP7 BCoV NB showed no detectable signals (Fig 2J) . We confirmed its specificity towards OAcSiasOAc-Sias in base and mild periodate-oxidized BSM. The data (Suppl Fig S12G) explains that SGRP7 BCoV binds BSM in OAc-dependent manner, and after depletion of OAc esters resulted in the dramatic reduction in SGRP7 BCoV 's binding, comparable to loss of binding after complete depletion of Sias.

SGRP8 TeT exhibits very specific binding towards di-Sia linkages, the sialoglycan moieties mostly represented by gangliosides in biological system. As a result, probe SGRP8 TeT showed no detectable binding with tested against sera in ELISA experiment (Suppl. Fig S13A) . In an ELISA experiment with immobilized purified gangliosides, SGRP8 TeT showed dose dependent binding towards di-sia oligosaccharide (GD1, GD3, GT1) discriminating from the mono-sia oligosaccharides (GM1, GM3) and polysia oligosaccharides conformations (Colominic acid) ( Fig   2H) . The observed results from ganglioside binding experiments are in complete agreement with the sialoglycan microarrays performed with SGRP8 TeT and confirms the advantage of the probe over native TeT-HCR (Fig 1, Suppl. Fig S10 A & B) . As anticipated, the nonbinding mutant SGRP8 TeT NB showed no detectable signals, signifying its utility as control for SGRP8 TeT 's specificity ( Fig 2H) .

SGRP9 PToV binds to 9-OAc-Sias that are represented by all mammalian sera included for binding assays (Suppl Table-1 ). In observed results, SGRP9 PToV demonstrated remarkably high affinity towards rat and Cmah -/mouse serum, suggesting their high proportions of Neu5,9Ac2 (Fig 2I) .

However, relatively lower binding to rabbit serum, as detected by signals in ELISA experiment was interesting as rabbit serum contained the highest fraction of Neu5,9Ac2 among the tested sera, but the basis of such variance is not known. It is clear from the serum-binding data of the SGRPs that those can demonstrate the presence or absence of the preferred ligand, but that this may not always measure the proportions relative to other Sia types within the serum. No detectable signals from similar binding assay with SGRP9 PToV NB confirms that SGRP9 PToV binding was specific. As observed in different ELISA experiments with OAc depleted sera, SGRP9 PToV 's binding to mammalian sera including rat and Cmah -/mouse showed a linear and reproducible binding exclusive to base labile OAc esters (Suppl Fig S12H) . The data showed that depletion of non-Oacetylated Sias doesn't influence SGRP9 PToV binding significantly while removal of OAc esters from Sias, or complete diminution of Sia population abolished its binding to sera (Suppl Fig  S12H) . These results together with sialoglycan microarray data (Fig1) confirm that SGRP9 PToV exhibits very strong preferences towards 9OAcSias and does not interact with nonsialylated structures or proteins in complex biological samples.

To confirm that SGRPs are applicable to routine methods of glycoprotein analysis, we assessed SGRP's qualitative detection of sialoglycoproteins by western blots. The gel electrophoresis and Western blotting protocol was modified to minimize loss of sensitive OAc-Sias (110, 111) . As observed, SGRP1 YenB bound to all 9 sera included in the experiment, which agrees with the observation from serum binding ELISA experiments (Fig. 3A) . SGRP2 PltB also bound to sera in accordance with their Neu5Ac contents, with a noticeable difference between its affinity for WT

and Cmah -/mouse sera (Fig. 3C) . SGRP3 Hsa and SGRP6 SNA showed binding to all sera, a pattern that was also observed in serum binding ELISAs (Fig. 3E & 3K) . SGRP4 MHV exclusively bound to guinea pig and horse sera (Fig. 3G) , while SGRP9 PToV exhibited high binding towards rat, rabbit

and Cmah -/mouse sera (Fig. 3N) , directly corresponding to OAc-Sia contents of these sera (Suppl Table 1 ). Interestingly, SGRP7 BCoV showed significant binding with multiple sera which differs from our observations with sera binding ELISA experiments. In ELISA, SGRP7 BCoV showed insignificant binding to sera and the overall binding pattern varied between experiments, suggesting a lack of linear binding behavior. We speculate that changes in pH and temperature during gel electrophoresis or blotting may result in migration of OAc esters, resulting in binding in western blotting, but we did not investigate this in detail. Blots, interrogated with non-binding variants of SGRPs (Fig. 3) did not show any binding to sera, suggesting Sia specific binding of SGRPs to sera. As SGRP8 TeT did not bind sera in ELISA it was excluded from western blot analysis of serum proteins.

Sias. The panel shows the typical binding patterns observed with each of the probes (red color indicates binding) (Fig. 4) . The non-binding control shows no binding to any of the sections, as expected. SGRP1 YenB detects mucins and blood vessels in many organs, and this is best demonstrated in the sections of kidney, where the glomeruli are highlighted with this probe ( Fig   4A) . The glomeruli, as well as the capillary blood vessels between the tubules are prominent in the wild type mouse, while in the Cmah -/mouse the capillaries between tubules are not as prominent ( Fig 4B) . The non-binding control shows no binding to any of the sections, as expected ( Fig 4C) .

SGRP2 PltB detects mucins and blood vessels in many organs, and this is best demonstrated in the sections of kidney, where the glomeruli are highlighted, and also the capillaries in between the tubules are visible (Fig 4D & E) . The non-binding control shows no binding to any of the sections, as expected (Fig 4F) . SGRP3 Hsa detects mucins and blood vessels in many organs, and this is best demonstrated in the sections of kidney, where the glomeruli are prominently highlighted (Fig 4G) .

The binding to the kidney glomeruli in Cmah -/mouse is slightly more prominent (Fig 4H) . The non-binding control shows no binding to any of the sections, as expected (Fig 4I) . SGRP4 MHV showed selective detection of mucins, and this is best demonstrated here in the mucin contained within the acini of pancreas. Staining was faint in the wild type and was much more prominently identified in the Cmah null animal (Fig 4J &K) . The islets of the pancreas (the endocrine portion) and the non-binding control show no evidence of binding (Fig 4L) . SGRP5 IgY detects blood vessels in many organs and demonstrated here by the detection of the capillaries within the sections from the pancreas in wild type, but not in Cmah -/mice (Fig 4M &N) . The non-binding control shows no binding to any of the sections (Fig 4O) . SGRP6 SNA detects mucins and blood vessels in many organs. Here we observe that SGRP6 SNA detects blood vessels in the pancreas of the Cmah -/mouse much better than it does in the wild type animal (Fig 4P & Q) . The tissue sections were incubated with secondary antibody Cy3-SA and served as control for SGRP6 SNA specificity, and shows no binding to any of the sections, as expected ( Fig 4R) . SGRP7 BCoV detects blood vessels in some organs but also detected white matter in the brain of the Cmah -/mouse extremely well (Fig 4T) .

The non-binding control shows no binding to any of the sections. (Fig 4U) . SGRP8 TeT detected large areas of the non-nuclear neuropil in the brain from both the wild type and in the Cmah -/mouse. The white matter in the brain from the Cmah -/mouse was even more prominent, and the non-binding control showed no binding to any of the sections (Fig 4V, W & X). SGRP9 PToV detected mucins and also red blood cells in many of the organs However, in sections of liver from the Cmah -/mouse, there was an abnormally high expression in the sinusoidal endothelial cells around the central vein, indicating right heart failure in the Cmah -/mouse (the portal triads, have two sources of blood supply and are thus the better perfused areas in the liver) (Fig 4Y & Z) . The non-binding control showed no binding to any of the sections, as expected ( Fig 4Z1) .

We performed flow cytometry experiments with mammalian RBCs to demonstrate in situ detection of extracellular Sias by SGRPs (Fig. 5 ). As shown in Fig 5A, SGRP1 YenB bound with RBCs from all 9 animal sources tested, while its nonbinding version SGRP1 YenB NB didn't show any binding (Fig 5A) . In general, the total fluorescence intensity for nonbinder probes remained comparable to autofluorescence (RBCs without any treatment) and antibody control (RBCs detected with SA-PE only). SGRP2 PltB bound with all RBCs except wild type mouse. The most robust bindings of SGRP2 PltB were detected with Cmah -/mouse, guinea pig, rabbit and rat followed by goat and human RBCs ( Fig   5B) . SGRP2 PltB NB didn't show any noticeable binding with RBCs from any source. SGRP3 Hsa bound with all types of RBCs with maximum binding detected from guinea pig, goat and rat RBCs and minimum with rabbit, indicating variable abundance of a2-3Sias on these erythrocytes ( Fig   5C) . SGRP3 Hsa NB didn't bind to any RBC type significantly. SGRP4 MHV showed no noticeable binding to any RBC included in experiment, and the binding as detected from SGRP4 MHV and SGRP4 MHV NB remained comparable, suggesting absence of 4OAcSias in extracellular surface of these RBCs (Fig 5D) . SGRP5 IgY bound with all RBCs except from Cmah -/mouse as anticipated ( Fig 5E) . Remarkably, SGRP5 IgY also didn't bind strongly to guinea pig and rat RBCs, suggesting less abundant Neu5Gc in these RBCs in comparison to mouse, horse and rabbit. SGRP5 IgY NB showed negligible detection, as expected from a nonbinding control probe. A stronger SGRP6 SNA binding was detected with human, guinea pig and rabbit in comparison to goat, sheep and horse ( Fig 5F) . Taking together with SGRP3 Hsa 's binding to RBCs, the relative abundance of a2-3Sias over a2-6Sias can be inferred for certain mammalian RBCs like goat, sheep and guinea pig. In absence of nonbinding mutant of SGRP6 SNA , the results are provided with autofluorescence and fluorescence antibody controls. The 7,9-diOAc-Sia-specific binder SGRP7 BCoV showed no appreciable binding in flow cytometry experiment, suggesting undetectable amounts of its ligand in tested RBCs (Fig 5G) . The resultant binding of SGRP7 BCoV and SGRP7 BCOV NB remains comparable with RBCs; the results showed agreement with probe's response with serum ELISA experiment, suggesting lack of SGRP7 BCoV binding in absence of its exclusive ligand 7,9-diOAc-Sia. a2-8-linked disialyl-oligosaccharides specific probe SGRP8 TeT didn't show any binding with RBCs tested (Suppl Fig S13B) and hence a set of GD3 transfected CHOK1 cells were used to investigate efficiency of SGRP8 TeT in flow cytometry experiment. As shown in Fig 5I, in a2-3-Sias, Neu5Ac and 9OAcSias9-OAc-Sias than a2-6-Sias, Neu5Gc and 4OAc4-OAc-Sias.

In this study we exploited naturally evolved Sia-recognizing microbial proteins to develop a feasible approach to design and derive sialoglycan-detecting probes, and applied the approach to develop and characterize a set of practicable probes recognizing the most predominant classes of mammalian Sia types. The study also reviewed and re-examined current standing of traditional probes or probe-like molecules that have been reported against known diversity of mammalian Sia types. We reviewed, assessed, and experimentally analyzed several probes to compare their suitability for use as updated SGRPs. In this process, we successfully identified an alternative for

Maackia lectins in the form of SGRP3 Hsa . The report does underline the utility of conventional a2-6Sia-binding Sambucus nigra lectin which appeared to be better than several microbial and mammalian proteins tested or reviewed in this study. Among developed probes; SGRP2 PltB , SGRP4 MHV , SGRP8 TeT and SGRP9 PToV represent novel probes for their class of Sia molecules, while SGRP1 YenB and SGRP3 Hsa showed substantial improvement over previously known probes.

SGRP5 IgY was also included in the final set, and SGRP6 SNA remained unique as we could not identify better alternative from microbial sources. Neu5Gc-specific microbial proteins showed utility but could not match the specificity and robustness of anti-Neu5Gc IgY, that was finally selected as SGRP5 IgY . An exception to SGRPs set, SGRP7 BCoV is characterized as an imperfect probe that is not completely selective for 7OAcSias, and that must be updated with more precise SGRP7 if one is identified in the future. Similarly, if a new probe is developed that is specific for Neu5Gc, that would replace the SGRP5 IgY which is currently selective for 7-OAc-Sias.

There are efforts ongoing by other groups, both in academic and industry to provide state of art sialoglycan detecting probes, and we attempted to review of most such studies and theoretically compared SGRPs with those molecules. Our focus remained on merits of proposed SGRPs and their utilities for a common biological science investigator. To have a consolidated assumption about the 'best' available probe for any given sialoglycan class, a real time comparison is required which is outside the scope of this study. In conclusion, this study provides a comprehensive set of probes for mammalian Sia types, designed and developed for the non-sialic acid experts. Several tests of demonstration of SGRPs specificity confirms their utility as practicable probes which can, and we expect SGRPs to be adapted by both experts and non-experts as tools of Sia recognition in their studies.

The full-length coding region of YESubB (423 bp) incorporating a 3' Hisx6 tag in the bacterial expression vector pBAD18 was kindly provided by James Paton and is described elsewhere. The corresponding nonbinding mutant YESubB (S31A; Y100F) was engineered from the wt template above using the Q5

Site-Directed Mutagenesis Kit (New England BioLabs) and sequence verified. Constructs were sequence verified.

The HsaBR sequence and its corresponding non-binding control HsaBR(R340E) (709 bp) in the bacterial expression vector pGEX-3X (Millipore Sigma) was cloned by Paul Sullam's Laboratory and described elsewhere. HsaBR/pGEX-3X and HsaBR(R340E)/pGEX-3X were subsequently modified to incorporate a 3' SNAPf_Hisx6 tag.

Briefly, a Hisx6 sequence tag was inserted into the BamH1 and Xho1 sites of MCS2 of pSNAPf (New England Biolabs) to create pSNAPf_Hisx6. SNAPf_6xHis was amplified from this construct by PCR using the forward primer 5'-AAAAGAATTCAACCATGGACAAAGACTGCGAAA-3'

and reverse primer 5'-TTTTGAATTCATTAGTGATGGTGATGGTGATGGGA-3';

EcoR1 site underlined. PCR products were digested with EcoR1 and sub-cloned into the EcoR1 site of HsaBR/pGEX-3X and HsaBR(R340E)/pGEX-3X above. Constructs were sequence verified. Deletion of S106 and T107 was performed from the wt template above using the Q5 Site-Directed Mutagenesis Kit (New England BioLabs) and sequence verified. Mutant S106;T107 was cloned into pET28b which had been modified to contain a 3' SNAPf_Hisx6 tag. This was subsequently engineered to contain an S12A mutation (non-binding) using Q5 mutagenesis.

CD22-Fc_ACP -A CD22 cDNA fragment encoding the first two Ig-like domains fused to an EK-hIgG-Fc fragment was amplified by PCR and cloned into the mammalian expression vector pACPtag(m)-2 (New England Biolabs). Table 1 Ranks; Red (100%, or maximum), Blue (0%, or minimum). Markedly reduced or absent binding was seen with the no-binding control probes studied simultaneously (See Supplementary Figure   S4 ). 

Essentials of Glycobiology

Advances in the biology and chemistry of sialic acids

Exploration of the Sialic Acid World

Sialic acid utilization by bacterial pathogens

Sialic Acid Receptors of Viruses

Evolutionary conservation of human ketodeoxynonulosonic acid production is independent of sialoglycan biosynthesis

Essentials of Glycobiology

The interaction of wheat germ agglutinin with sialoglycoproteins. The role of sialic acid

Purification and macromolecular properties of a sialic acid-specific lectin from the slug Limax flavus

Incorporation of a non-human glycan mediates human susceptibility to a bacterial toxin

Host adaptation of a bacterial toxin from the human pathogen Salmonella Typhi

The role of 9-O-acetylated glycan receptor moieties in the typhoid toxin binding and intoxication

Studies on hemagglutinins from Maackia amurensis seeds

Characterization of the carbohydrate binding specificity of the leukoagglutinating lectin from Maackia amurensis. Comparison with other sialic acid-specific lectins

Effects of sialic acid substitutions on recognition by Sambucus nigra agglutinin and Maackia amurensis hemagglutinin

Strong affinity of Maackia amurensis hemagglutinin (MAH) for sialic acid-containing Ser/Thr-linked carbohydrate chains of N-terminal octapeptides from human glycophorin A

Enhanced 3-O-sulfation of galactose in Asn-linked glycans and Maackia amurensis lectin binding in a new Chinese hamster ovary cell line

Monomeric, monovalent derivative of Maackia amurensis leukoagglutinin. Preparation and application to the study of cell surface glycoconjugates by flow cytometry

Novel aspects of sialoglycan recognition by the Siglec-like domains of streptococcal SRR glycoproteins

The Streptococcus gordonii surface proteins GspB and Hsa mediate binding to sialylated carbohydrate epitopes on the platelet membrane glycoprotein Ibalpha

Oral streptococci utilize a Siglec-like domain of serine-rich repeat adhesins to preferentially target platelet sialoglycans in human blood

Binding of the Streptococcus gordonii surface glycoproteins GspB and Hsa to specific carbohydrate structures on platelet membrane glycoprotein Ibalpha

Structural analysis of naturally occurring sialic acids

O-acetylation of sialic acids

B cell antigen receptor signal strength and peripheral B cell development are regulated by a 9-O-acetyl sialic acid esterase

Rethinking mechanisms of autoimmune pathogenesis

Biosynthesis and turnover of Oacetyl and N-acetyl groups in the gangliosides of human melanoma cells

4-O-acetyl-N-acetylneuraminic acid in the N-linked carbohydrate structures of equine and guinea pig alpha 2-macroglobulins, potent inhibitors of influenza virus infection

Enzymatic 4-O-acetylation of N-acetylneuraminic acid in guinea-pig liver

Detection of 4-Oacetyl-N-glycolylneuraminyl lactosylceramide as one of tumor-associated antigens in human colon cancer tissues by specific antibody

Survey of Hanganutziu and Deicher antibodies in operated patients

Two chicken monoclonal antibodies specific for heterophil Hanganutziu-Deicher antigens

Purification and characterization of an O-acetylsialic acid-specific lectin from a marine crab Cancer antennarius

Sialic acid-specific lectin from Tritrichomonas foetus

The receptor-destroying enzyme of influenza C virus is neuraminate-O-acetylesterase

Isolated HE-protein from hemagglutinating encephalomyelitis virus and bovine coronavirus has receptor-destroying and receptor-binding activity

Influenza C virus uses 9-O-acetyl-N-acetylneuraminic acid as a high affinity receptor determinant for attachment to cells

The influenza C virus glycoprotein (HE) exhibits receptor-binding (hemagglutinin) and receptor-destroying (esterase) activities

Human and bovine coronaviruses recognize sialic acid-containing receptors similar to those of influenza C viruses

Infectious salmon anemia virus specifically binds to and hydrolyzes 4-O-acetylated sialic acids

The hemagglutinin-esterase of mouse hepatitis virus strain S is a sialate-4-O-acetylesterase

Sequence of mouse hepatitis virus A59 mRNA 2: indications for RNA recombination between coronaviruses and influenza C virus

Heterogeneity of gene expression of the hemagglutinin-esterase (HE) protein of murine coronaviruses

Identification of a new transcriptional initiation site and the corresponding functional gene 2b in the murine coronavirus RNA genome

The murine coronavirus hemagglutinin-esterase receptor-binding site: a major shift in ligand specificity through modest changes in architecture

Distribution of O-Acetylated Sialic Acids among Target Host Tissues for Influenza Virus. mSphere 2, 48

Generation of two murine monoclonal antibodies that can discriminate N-glycolyl and N-acetyl neuraminic acid residues of GM2 gangliosides

Monoclonal antibody R24 distinguishes between different N-acetyl-and N-glycolylneuraminic acid derivatives of ganglioside GD3

Hanganutziu-Deicher heterophile antigen in human retinoblastoma cells

Detection of gangliosides as N-glycolylneuraminic acid-specific tumor-associated Hanganutziu-Deicher antigen in human retinoblastoma cells

Tumor-associated expression of glycosphingolipid Hanganutziu-Deicher antigen in human cancers

Characterization of N-glycolylneuraminic acid-containing gangliosides as tumorassociated Hanganutziu-Deicher antigen in human colon cancer

Specific expression of unusual GM2 ganglioside with Hanganutziu-Deicher antigen activity on human colon cancers

Sensitive and specific detection of the non-human sialic Acid N-glycolylneuraminic acid in human tissues and biotherapeutic products

Structure aided design of a Neu5Gc specific lectin

Detection of N-glycolylneuraminic acid biomarkers in sera from patients with ovarian cancer using an engineered N-glycolylneuraminic acid-specific lectin SubB2M

Specificity and utility of SubB2M, a new N-glycolylneuraminic acid lectin

A red meat-derived glycan promotes inflammation and cancer progression

Sialic acid receptor detection in the human respiratory tract: evidence for widespread distribution of potential binding sites for human and avian influenza viruses

The Human Lung Glycome Reveals Novel Glycan Ligands for Influenza A Virus

Sialic acid-specific lectins: occurrence, specificity and function

Cloning, expression in Escherichia coli and characterization of the recombinant Neu5Acalpha2,6Galbeta1,4GlcNAc-specific highaffinity lectin and its mutants from the mushroom Polyporus squamosus

Structure and binding analysis of Polyporus squamosus lectin in complex with the Neu5Ac{alpha}2-6Gal{beta}1-4GlcNAc human-type influenza receptor

The oligosaccharide binding specificities of CD22beta, a sialic acid-specific lectin of B cells

Natural ligands of the B cell adhesion molecule CD22 beta can be masked by 9-O-acetylation of sialic acids

Natural ligands of the B cell adhesion molecule CD22beta carry N-linked oligosaccharides with alpha-2,6-linked sialic acids that are required for recognition

Sialoadhesin, myelin-associated glycoprotein and CD22 define a new family of sialic acid-dependent adhesion molecules of the immunoglobulin superfamily

Loss of N-glycolylneuraminic acid in human evolution. Implications for sialic acid recognition by siglecs

The HMW2 adhesin of non-typeable Haemophilus influenzae is a human-adapted lectin that mediates high-affinity binding to 2-6 linked N-acetylneuraminic acid glycans

The elderberry (Sambucus nigra L.) bark lectin recognizes the Neu5Ac(alpha 2-6)Gal/GalNAc sequence

Purification and characterization of a Neu5Ac alpha 2-->6Gal beta 1-->4GlcNAc and HSO3(-)-->6Gal beta 1-->GlcNAc specific lectin in tuberous roots of Trichosanthes japonica

Discovery and characterization of sialic acid Oacetylation in group B Streptococcus

Characterization of the sialic acid synthase from Aliivibrio salmonicida suggests a novel pathway for bacterial synthesis of 7-O-acetylated sialic acids

Differentially regulated expression of 9-O-acetyl GD3 (CD60b) and 7-O-acetyl-GD3 (CD60c) during differentiation and maturation of human T and B lymphocytes

Characterization of the enzymatic 7-Oacetylation of sialic acids and evidence for enzymatic O-acetyl migration from C-7 to C-9 in bovine submandibular gland

Sialic acids: metabolism of O-acetyl groups

Genetic variation in plasma thyroxine levels and minimal metabolic rates of the mouse, Mus musculus

Attachment of mouse hepatitis virus to O-acetylated sialic acid is mediated by hemagglutinin-esterase and not by the spike protein

Identification of a coronavirus hemagglutinin-esterase with a substrate specificity different from those of influenza C virus and bovine coronavirus

Structural basis for ligand and substrate recognition by torovirus hemagglutinin esterases

The S protein of bovine coronavirus is a hemagglutinin recognizing 9-O-acetylated sialic acid as a receptor determinant

Bovine coronavirus uses N-acetyl-9-O-acetylneuraminic acid as a receptor determinant to initiate the infection of cultured cells

Production and molecular characterization of clinical phase i anti-melanoma mouse IgG3 monoclonal antibody R24

Localization of GD2-specific monoclonal antibody 3F8 in human osteosarcoma

Immunotherapeutic strategies in neuroblastoma: antitumoral activity of deglycosylated Ricin A conjugated anti-GD2 antibodies and anti-CD3xanti-GD2 bispecific antibodies

Treatment of high-risk neuroblastoma with anti-GD2 antibodies

Mouse monoclonal antibodies detecting disialogangliosides on mouse and human T lymphomas

Structural and immunological characterization of O-acetylated GD2. Evidence that GD2 is an acceptor for ganglioside O-acetyltransferase in human melanoma cells

Myelin-associated glycoprotein interacts with ganglioside GT1b. A mechanism for neurite outgrowth inhibition

Total synthesis of a cholinergic neuron-specific ganglioside GT1a alpha: a high affinity ligand for myelin-associated glycoprotein (MAG)

The ceramide moiety of disialoganglioside (GD3) is essential for GD3 recognition by the sialic acid-binding lectin SIGLEC7 on the cell surface

Human melanoma antigen Oacetylated ganglioside GD3 is recognized by Cancer antennarius lectin

Purification and carbohydrate-binding specificity of Agrocybe cylindracea lectin

Sugar-lectin interactions: how does wheat-germ agglutinin bind sialoglycoconjugates

Porcine Sapelovirus Uses α2,3-Linked Sialic Acid on GD1a Ganglioside as a Receptor

Helicobacter pylori SabA binding gangliosides of human stomach

Gangliosides in human, cow and goat milk, and their abilities as to neutralization of cholera toxin and botulinum type A neurotoxin

Characterization of the receptor-binding domain of tetanus toxin

Identification of a binding site for ganglioside on the receptor binding domain of tetanus toxin

Gangliosides as high affinity receptors for tetanus neurotoxin

Molecular basis for tetanus toxin coreceptor interactions

Diversity in the sialic acids

An unique specificity of a sialic acid binding lectin AchatininH, from the hemolymph of Achatina fulica snail

Selective inactivation of influenza C esterase: a probe for detecting 9-O-acetylated sialic acids

Use of influenza C virus for detection of 9-O-acetylated sialic acids on immobilized glycoconjugates by esterase activity

9-O-acetylated sialic acids have widespread but selective expression: analysis using a chimeric dual-function probe derived from influenza C hemagglutinin-esterase

Recombinant influenza C hemagglutininesterase as a probe for sialic acid 9-O-acetylation

The release and purification of sialic acids from glycoconjugates: methods to minimize the loss and migration of O-acetyl groups

O-acetylation and de-O-acetylation of sialic acids. Purification, characterization, and properties of a glycosylated rat liver esterase specific for 9-O-acetylated sialic acids

Determination of mono-O-acetylated N-acetylneuraminic acids in human and rat sera by fluorometric high-performance liquid chromatography

A simple method for assessment of human anti-Neu5Gc antibodies applied to Kawasaki disease

Siglec (Sialic acid-binding immunoglobulin-type lectins)

YenB (Yersinia enterocolitica, toxin subunit B)

This work was supported by NIH Grants U01CA199792 and R01GM32373 (to A.V.), and additional generous financial support from BioLegend, San Diego.

The authors declare no competing interests.